Functional inactivation of the retinoblastoma tumor suppressor gene product (RB) is a common event in human cancers. Classically, RB functions to constrain cellular proliferation, and loss of RB is proposed to facilitate the hyperplastic proliferation associated with tumorigenesis. To understand the repertoire of regulatory processes governed by RB, two models of RB loss were utilized to perform microarray analysis. In murine embryonic fibroblasts harboring germline loss of RB, there was a striking deregulation of gene expression, wherein distinct biological pathways were altered. Specifically, genes involved in cell cycle control and classically associated with E2F-dependent gene regulation were upregulated via RB loss. In contrast, a program of gene expression associated with immune function and response to pathogens was significantly downregulated with the loss of RB. To determine the specific influence of RB loss during a defined period and without the possibility of developmental compensation as occurs in embryonic fibroblasts, a second system was employed wherein Rb was acutely knocked out in adult fibroblasts. This model confirmed the distinct regulation of cell cycle and immune modulatory genes through RB loss. Analyses of ciselements supported the hypothesis that the majority of those genes upregulated with RB loss are regulated via the E2F family of transcription factors. In contrast, those genes whose expression was reduced with the loss of RB harbored different promoter elements. Consistent with these analyses, we found that disruption of E2F-binding function of RB was associated with the upregulation of gene expression. In contrast, cells harboring an RB mutant protein (RB-750F) that retains E2F-binding activity, but is specifically deficient in the association with LXCXE-containing proteins, failed to upregulate these same target genes. However, downregulation of genes involved in immune function was readily observed with disruption of the LXCXE-binding function of RB.
Functional inactivation of the retinoblastoma tumor suppressor gene product (RB) is a common event in human cancers. Classically, RB functions to constrain cellular proliferation, and loss of RB is proposed to facilitate the hyperplastic proliferation associated with tumorigenesis. To understand the repertoire of regulatory processes governed by RB, two models of RB loss were utilized to perform microarray analysis. In murine embryonic fibroblasts harboring germline loss of RB, there was a striking deregulation of gene expression, wherein distinct biological pathways were altered. Specifically, genes involved in cell cycle control and classically associated with E2F-dependent gene regulation were upregulated via RB loss. In contrast, a program of gene expression associated with immune function and response to pathogens was significantly downregulated with the loss of RB. To determine the specific influence of RB loss during a defined period and without the possibility of developmental compensation as occurs in embryonic fibroblasts, a second system was employed wherein Rb was acutely knocked out in adult fibroblasts. This model confirmed the distinct regulation of cell cycle and immune modulatory genes through RB loss. Analyses of ciselements supported the hypothesis that the majority of those genes upregulated with RB loss are regulated via the E2F family of transcription factors. In contrast, those genes whose expression was reduced with the loss of RB harbored different promoter elements. Consistent with these analyses, we found that disruption of E2F-binding function of RB was associated with the upregulation of gene expression. In contrast, cells harboring an RB mutant protein (RB-750F) that retains E2F-binding activity, but is specifically deficient in the association with LXCXE-containing proteins, failed to upregulate these same target genes. However, downregulation of genes involved in immune function was readily observed with disruption of the LXCXE-binding function of RB.
Thus, these studies demonstrate that RB plays a significant role in both the positive and negative regulations of transcriptional programs and indicate that loss of RB has distinct biological effects related to both cell cycle control and immune function.
Introduction
The retinoblastoma tumor suppressor (RB) is a potent inhibitor of cell cycle progression that was initially identified based on bi-allelic inactivation in the pediatric cancer retinoblastoma (Sherr and McCormick, 2002; Cobrinik, 2005) . Many subsequent studies have demonstrated that RB function is compromised in a large fraction of human cancers, this is consistent with the model that deregulation of cell cycle control is a requisite component of tumorigenesis (Nevins, 2001; Sherr and McCormick, 2002; Cobrinik, 2005) . Owing to widespread inactivation of RB in cancer, the mechanism underlying tumor suppression has been the subject of intense scrutiny.
A critical function of RB is the regulation of gene expression. The RB protein has weak, non-specific, DNA-binding activity. However, RB interacts strongly with a number of sequence specific DNA-binding transcription factors (Morris and Dyson, 2001; Frolov and Dyson, 2004) . Among these factors, the best understood is the E2F family of transcription factors (Morris and Dyson, 2001; Cam and Dynlacht, 2003; Frolov and Dyson, 2004; Cobrinik, 2005; Dimova and Dyson, 2005) . Generally, E2F functions as a heterodimer comprised of E2F and DP subunits. These factors interact with DNA elements in the promoters of a large number of cell cycle regulatory genes as determined by microarray-based gene expression (Ishida et al., 2001; Markey et al., 2002; Vernell et al., 2003) and chromatin immunoprecipitation (ChIP) analyses (Ren et al., 2002; Cam et al., 2004) . Specifically, E2F complexes have been attributed to the appropriate control of DNA replication, DNA repair, apoptosis and G2/M regulation. Most of the E2F family members harbor transcriptional activation domains and stimulate the expression of target genes (Cam and Dynlacht, 2003; Blais and Dynlacht, 2004; Dimova and Dyson, 2005) . By interacting with E2F proteins, RB masks the transcriptional activation domains of these proteins (Qin et al., 1995) . Additionally, RB functions to recruit corepressor activities to functionally repress E2F-mediated gene expression (Trouche et al., 1997; Brehm et al., 1998; Strobeck et al., 2000) . Thus, activation of RB represses the expression of E2F-regulated genes and mediates the inhibition of cell cycle progression.
To mediate physiological proliferation, RB activity is regulated during cell cycle progression. Mitogenic signaling cascades stimulate the activity of cyclindependent kinase (CDK) complexes, which phosphorylate RB (Cobrinik, 2005) . This phosphorylation attenuates the interaction of RB with E2F family members (Knudsen et al., 1998) . Thus, as cells progress through the cell cycle, RB-mediated repression is alleviated, and it is believed that this event is critical for cell cycle progression. During tumorigenesis, RB is functionally inactivated through a multitude of mechanisms. Strikingly, these disparate mechanisms all impinge on RB-mediated repression of transcription by disrupting the interaction with E2F and corepressors.
While the targeting of E2F activity represents a wellappreciated aspect of RB function, there are a number of additional proteins that interact with RB. For example, RB interacts with an excess of 30 additional transcription factors (Wang et al., 1994; Morris and Dyson, 2001 ). Many of these proteins and additional transcriptional modulators interact with the RB A/B pocket through an LXCXE motif. There are also data that RB can function as a transcriptional activator in specific settings. For example, it has been previously observed that RB-null cells have reduced expression of major histocompatibility complex class I and II proteins, and that restoration of RB induces the expression of these genes (Lu et al., 1994; Zhu et al., 1999; Eason et al., 2001) . Additionally, RB can bind to JunD, NeuroD1, CBFA1, PU.1 and the androgen receptor to mediate transcription factor activation (Thomas et al., 2001; Xin et al., 2003; Iavarone et al., 2004; Batsche et al., 2005) . Given the prevalence of RB inactivation in cancer, it is important to understand the range of transcriptional changes occurring through RB loss.
Results
Chronic RB loss modifies the expression of known E2F-regulated genes To initially probe the influence of RB loss on gene expression programs, we utilized murine embryonic fibroblasts (MEFs). As expected, RbÀ/À MEFs are deficient in the expression of the RB protein ( Figure 1a ). These cells exhibit relatively similar cell cycle distributions ( Figure 1b ) and proliferation rates (Figure 1c) . However, these asynchronously proliferating RbÀ/À MEFs harbor increased expression of specific gene products that are under E2F control (Figure 1d ). For example, the protein levels of PCNA, MCM7 and Cyclin A were upregulated in the RbÀ/À MEFs. Ontology-based analysis showed that the preponderance of upregulated genes was involved in cellular proliferation, DNA metabolism (e.g., DNA replication) and transcriptional processes (Figure 2b and Supplementary  Table 1) . Strikingly, we found a significant fraction of genes (129 in total) were downregulated in the RbÀ/À MEFs (Figure 2a ). These genes are not involved in cell cycle progression and have not been identified previously on microarrays using the overexpression of either RB or E2F proteins (Ishida et al., 2001; Markey et al., 2002; Vernell et al., 2003) . Analysis with the gene ontology programs demonstrated that most of the genes are associated with processes related to immune responses, particularly those induced by pathogens or injuries ( Figure 2c and Supplementary Table 1), including a wide spectrum of chemokines, complement factors, cell surface antigens and receptors (Supplementary Data 1). To confirm that the RNA levels of these genes were reduced in the absence of RB, a selected set of these transcripts were analysed by reverse transcriptase polymerase chain reaction (RT-PCR). As shown in Figure 3a , we confirmed that the levels of Rb RNA were 
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+/+ Rb reduced, while conventionally E2F-regulated genes such as MCM7 exhibit increased RNA levels in RbÀ/À MEFs. In contrast, the RNA levels of the immune/ pathogen response-related genes were reduced in RbÀ/À MEFs relative to Rb þ / þ MEFs ( Figure 3b ).
Acute RB loss deregulates gene expression
The above results indicate that loss of RB in primary fibroblasts can both enhance and attenuate the expression of multiple genes involved in disparate biological processes. However, this finding could be due in part to adaptive changes that occur during development of the RbÀ/À embryos, for example, upregulation of other pocket proteins (Sage et al., 2003) . Therefore, we utilized a cell culture system wherein RB can be inactivated acutely. In this system, adult fibroblasts of Rb loxP/loxP mice are isolated and cultured (Mayhew et al., 2004) . Infection of these cells with adenoviruses encoding Cre recombinase led to a rapid and efficient recombination of the Rb gene ( Figure 4a ). As in the MEF system, the loss of RB results in minimal change in cell cycle distribution ( Figure 4b and c), but leads to the accumulation of known E2F gene products ( Figure 4d ). Thus, this system can be utilized as a model for acute RB loss. Asynchronous Rb loxP/loxP cells were infected with either green fluorescent protein (GFP) or GFP and Crerecombinase (GFP-Cre) encoding adenoviruses and harvested for microarray analyses at 72 or 144 h postinfection. The primary microarray data were referenced to GFP 72 h controls and queried for genes that were significantly altered using a Welch t-test and 5% Benjamani Hochberg false discovery rate using GeneSpring. This analysis resulted in a list of 528 genes upregulated or downregulated by the loss of RB ( Figure 5a and Supplementary Data 2). Many of the upregulated genes (273 total) confirmed that loss of RB resulted in the increased expression of known E2F target genes. Thus, the upregulation of E2F-regulated genes occurs both acutely and as a chronic response to RB. Using gene ontology analyses, we found that genes upregulated by acute RB loss were involved in processes virtually identical to those found with the chronic loss of RB (Figure 5b and Supplementary Table 2) . We also observed a significant downregulation of specific target genes with the acute loss of RB (Figure 5c and  Supplementary Table 2 ). These genes were observed to be largely involved in immune response to pathogen. The regulation of these targets was further confirmed by real-time quantitative PCR (Figure 5d ). Thus, the acute loss of RB recapitulates the results with chronic loss in the MEFs, confirming that RB loss deregulates gene expression programs involved in both cell cycle control and immune function.
Combinatorial analyses define genes tightly regulated in multiple contexts
To provide a comprehensive account of genes with expression modified by the loss of RB, all of the data from both models were combined and evaluated for significant patterns using several different approaches. For this, data sets were combined from the separate experiments using a normalization and referencing strategy in which the gene expression level for each gene in an experimental series was examined relative to the mean of its expression in control samples within its series. Regulated genes were identified in each series using a Welch t-test, Po0.05, and then ranked according to highest fold-regulated within condition-specific comparisons. Four different gene lists were obtained (597, 331, 528 and 243), which when pooled generated a list of 1166 genes/EST entries reproducibly modified via the loss of RB (Supplementary Data 3). These data were subjected to hierarchical clustering ( Figure 6a ). From these analyses, there were two main clusters that exhibited highly conserved changes in behavior. Genes in clusters 1 and 2 were upregulated with RB loss and contained a total of 310 entries. The behavior of all genes in each cluster is depicted in Figure 6b . The majority of the genes in clusters 1 and 2 are involved in cell cycle regulation and transcriptional control. A summary listing of genes in major categories is shown in Figure 7 . There were also a large number of genes downregulated by RB loss. The overall behavior of these genes was relatively heterogeneous, being downregulated preferentially in one model. For example, in cluster 3 (composed of 268 genes), virtually all of the genes are downregulated as a result of acute RB loss. However, only 97 genes within cluster 3 were downregulated in both models (denoted by green bars). An abbreviated list of the genes from this cluster is shown in Figure 7 . Strikingly, while heterogeneity was observed at the level of individual genes, the overall function of genes within the downregulated cluster and subcluster is related to immune response or response to pathogen/injury, including cell surface molecules, complement factors and genes involved in interferon signaling.
Distinct cis-element composition of genes differentially regulated with RB loss The finding that RB loss differentially regulated gene expression led us to interrogate cis-elements that govern distinct gene behavior. Specifically, genes from clusters 1-3 were analysed. The murine and human sequences were aligned using the Trafac server (Jegga et al., 2002) and the 500 base pairs upstream and downstream of the transcriptional start site were probed for presence of conserved E2F sites using the CisMols server (Jegga et al., 2005) . Initially, we determined the average number of conserved E2F sites present in each gene. These analyses demonstrated that E2F-binding sites are highly prevalent in activated genes, representing the 9th and 12th most prevalent transcription factor binding sites in clusters 1 and 2, respectively, with an average of approximately four E2F sites per gene (Figure 8a ). In contrast, in cluster 3 genes, E2F sites were significantly underrepresented (29th) and the relative number of E2F sites was significantly reduced (Figure 8a ). Recent evidence suggests that E2F elements are often dependent on neighboring sites for functional activity (Markey et al., 2002) . Therefore, we analysed each conserved E2F site for other binding sites within a window of 200 base pairs. Using this approach, we observed that a number of transcription factor binding sites cooccur with E2F sites and these sites were preferentially observed with clusters 1 and 2 (Figure 8b ). Importantly, several of these elements have been previously implicated in cooperating with E2F for gene regulation (e.g., CDE, MYB and AHR), suggesting that there is a significant difference in the promoter composition between genes upregulated and downregulated with RB loss. To determine if the difference in proximity to the E2F sites was indicative of overall differences in promoter composition, the 1 kb regions surrounding the transcription start sites were analysed for the presence of over 30 different conserved transcription factor binding sites (Figure 8c ). This analysis indicated that the two gene clusters upregulated with RB loss exhibited similar promoter compositions, wherein both common (SP1, MAZ and ETS) and relatively specific (CDE, HIF, ECAT and PCAT) binding sites were observed. In contrast, genes downregulated with RB loss exhibited a distinct profile of transcription factor binding sites. For these genes, a number of unique sites were observed, such as GATA, OCT1 and IRF that are involved in regulating genes involved in immune function. Therefore, these analyses demonstrate not only the paucity of E2F sites, but also an overall difference in promoter constitution between the two classes of genes. Combined, these data suggest that RB loss deregulates gene expression by acting at distinct classes of promoters.
Distinct RB functional domains are associated with upregulation versus downregulation of gene expression The data described above suggest that distinct regulatory interactions are responsible for the upregulation versus downregulation of gene expression. To explore this possibility, we employed two additional models of RB dysfunction. First, we utilized adenovirus E1A. This viral oncoprotein disrupts the association of RB with both the E2F family of transcription factors and a number of additional regulatory proteins that interact with the RB A/B pocket through an LXCXE motif. Second, we employed a new knock-in mouse model that harbors the N750F allele of RB (Bergseid and Wang, in preparation). This mutation completely compromises the binding of RB to LXCXE-containing proteins, without influencing binding to E2F proteins (Chen and Wang, 2000) . MEFs either wild type for RB and transduced with E1A or homozygous for the N750F allele were utilized to analyse changes in gene expression by microarray analyses on an Agilent platform (see Supplementary Information). As shown in Figure 9a , E1A resulted in a significant induction of genes that were upregulated by RB loss. This effect of E1A was not recapitulated by the N750F allele (Figure 9a) . Thus, the Cluster 2 Figure 7 Genes categorized by ontology. Genes in the upregulated clusters 1 and 2 include genes involved in the control of cell growth and division (DNA replication, mitosis, chromatin remodeling, apoptosis and so on). In contrast, genes in cluster 3, which were downregulated with RB loss, include genes involved in the immune response and complement systems.
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upregulation of defined RB target genes is dependent on the disruption of interactions with E2F, but not LXCXE-containing proteins. As discussed earlier, there is significant heterogeneity among genes downregulated with RB loss, while functional roles in immune function are largely conserved. When analysing genes associated with immune function, we found that E1A significantly downregulated gene expression (Figure 9b ). However, distinct from the upregulated genes, the N750F allele influenced gene expression in a manner consistent with E1A ( Figure 9b) . Thus, the LXCXE-binding function of RB plays a critical role in facilitating the expression of this class of genes.
Discussion
The activity of RB is compromised in the majority of human tumors (Nevins, 2001; Sherr and McCormick, 2002; Cobrinik, 2005) . The influence of this event on tumorigenesis is largely viewed as an effect on cell cycle progression, wherein the subsequent activation of E2F-regulated genes drives hyperplastic proliferation (Cam and Dynlacht, 2003; Blais and Dynlacht, 2004) . However, it is becoming increasingly clear that RB also plays positive roles in mediating additional responses that also contribute to tumor suppression (Cam and Dynlacht, 2003; Thomas et al., 2003; Blais and Dynlacht, 2004) .
Role of RB in attenuation of E2F-regulated genes
It is well appreciated that in specific contexts, RB can function to repress E2F-mediated gene expression (Nevins, 2001; Cobrinik, 2005) . The paradigms for this activity are based on ectopic expression of active alleles of RB or the use of p16ink4a, which activates endogenous pocket proteins. In both these contexts, a significant repression of E2F-regulated genes is observed (Markey et al., 2002; Vernell et al., 2003) . Such results however must be interpreted with caution since the ectopic expression of RB could usurp the physiological targets associated with the RB-related proteins, p107/ p130. Additionally, while the activation of RB and associated members is potentially important from the standpoint of specific anti-mitogenic signaling cascades, the pathological importance of RB represents those situations in which its activity is compromised. Here, we utilized two primary cell systems to specifically evaluate the influence of RB loss on gene expression. In both of these systems, there is a marked stimulation of E2F-regulated gene expression. Before microarrays utilizing overexpression of E2F proteins have defined targets that functionally contribute to DNA replication, DNA repair, G2/M progression, apoptosis and chromatin/ transcription. With the loss of RB in both model systems, each of these classes of E2F-regulated genes is clearly represented. Thus, these data indicate through the specific loss of only RB, numerous E2F-target genes are deregulated. Such a result has been reported in the MEF system on a similar platform (Black et al., 2003; Iovino et al., 2006) , although here we define additional genes that are upregulated with RB loss. Importantly, we also demonstrate that this effect on gene expression occurs within the span of a few days and is thus not dependent on chronic loss of RB. Our studies also indicate that the interaction with E2F proteins is critical for the modulation of these upregulated genes, as both complete RB loss and expression of E1A lead to the induction of such genes. In contrast, the LXCXEbinding motif of RB that is implicated in recruitment of corepressors and association with other transcriptional regulators had minimal influence on these target genes.
RB loss and downregulation of gene expression
While the E2F family of transcription factors are the best known targets of RB, a large number of additional transcription factors interact with RB (Kouzarides, 1995; Morris and Dyson, 2001) . Interestingly, RB functions as a co-activator for some of these transcription factors (Kouzarides, 1995 
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). This has been demonstrated for a variety of different classes of transcription factors that regulate discrete biological processes (e.g., MyoD, Androgen Receptor, Runx2 and NeuroD1). Therefore, a positive effect of RB on gene expression has not been reported in microarray analyses. Here, we found that RB loss had a significant effect in downregulating gene expression. Interestingly, among the three different systems utilized, there was significant heterogeneity between the individual genes that are downregulated with RB loss. This finding suggests that the function of RB in maintaining gene expression is highly context dependent, wherein even differences between fibroblast models yield significant changes in gene expression. However, despite the heterogeneity in the models utilized, the downregulated genes were highly enriched to function in the immune system and in response to pathogen. The influence of RB loss on immune response has been previously proposed. In studies investigating interferon g-regulated gene expression, there is a deficit in the induction of specific interferon-inducible genes in RB-deficient cells (Lu et al., 1994; Osborne et al., 1997; Zhu et al., 1999; Eason et al., 2001 ). This change in gene expression has been attributed to changes in chromatin structure and regulation of Oct-1 function (Osborne et al., 1997 (Osborne et al., , 2004 . Consistent with this mode of regulation, we find that Oct-1-binding sites are, in fact, observed at higher frequency in the promoter of genes that are downregulated with the loss of RB. Additionally, it has been observed that HPV-E7 (which downregulates RB activity) has a similar influence on gene expression (Arany and Tyring, 1996; Le Buanec et al., 1999) . This finding is consistent with our observations with adenovirus E1A. Thus, in the context of viral oncogenes, it is formally possible that targeting RB serves an advantage both by stimulating proliferation through E2F-regulated genes and impeding immune detection. Importantly, the effects of RB on maintaining target gene expression are dependent on the LXCXEbinding function of RB. This result is consistent with our in silico analyses that RB is utilizing distinct interactions to maintain the expression of genes, as opposed to mediating repression. Our studies indicate that such gene activation is presumably mediated through interactions between the RB A/B pocket and proteins harboring LXCXE motifs. In summary, these studies describe the influence of compromised RB function on gene expression. As expected, genes involved in cell cycle regulation and conventionally regulated via the E2F family of transcription factors were upregulated concomitantly with the loss of RB/E2F interactions. However, a large class of genes are downregulated as a result of RB deficiency and these genes are involved in immune functions. Combined, these data underscore the complexity of RB function and indicate that loss of RB compromises distinct facets of gene regulation.
Materials and methods

Cell culture
MEFs from wild-type, Rb À/À or Rb N750F/N750F mice were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/ml penicillin G, 100 mg/ml streptomycin sulfate, 1% glutamine and 0.001% bmercaptoethanol. The Rb N750F/N750F mice were generated using standard gene targeting approaches and expression of the allele confirmed (Bergseid and Wang, in preparation) . Adult fibroblasts from Rb exon 3 loxP/loxP mice were cultured as previously described (Mayhew et al., 2004) . MAFs were grown to passage three, infected with adenovirus encoding either GFP or GFP-Cre and cultured for 72 or 144 h postinfection. To achieve stable expression of E1A, viral supernatant was harvested from BOSC23 cells, added to plates that contained MEFs at 50% confluence, and 24 h postinfection, puromycin selection was introduced (4 mg/ml).
Microarray and cis-element analyses A detailed elaboration of the methods employed in the microarray and cis-element analyses is included in the supplemental section of this manuscript.
Antibodies
Immunoblotting was carried out with the following antibodies from Santa Cruz Biotechnology (Santa Cruz, CA, USA): cyclin A (C-19), b-tubulin (D-10), MCM7 (141.2), PCNA (PC10), RNR-M2 (I-15). Also utilized was anti-topoisomerase II-alpha (Topogen, Port Orange, FL, USA, 2011-1), RB (Becton Dickenson, Franklin Lakes, NJ, USA, 554136) and Vimentin (gift of Dr Wallace Ip).
Flow cytometry and bromodeoxyuridine incorporation
Flow cytometry (Welch and Wang 1995) and bromodeoxyuridine (BrdU) incorporation (Knudsen et al., 1998) analyses were carried out as previously described.
RT-PCR
Total RNA was harvested with Trizol (Life Technologies Inc., Carlsbad, CA, USA) according to the manufacturer's suggested protocol. RNA (1 mg) was reverse transcribed and 
